Among the DEGs involved in the dilated cardiomyopathy pathway, the expression levels of ANP, Calm1/2/3, Camk2a/d and Pde2/3/5a were decreased in the GCN2iB group (Figure 3D). Here, CAMK2A is linked to dilated cardiomyopathy.